Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05075122
Title Tolerability and Efficacy of UV1 Vaccine in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Planned for First-line Treatment With Pembrolizumab (FOCUS)
Acronym FOCUS
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Martin-Luther-Universität Halle-Wittenberg
Indications
Therapies
Age Groups: adult | senior
Covered Countries DEU

Facility Status City State Zip Country Details
Universitätsklinikum Aachen, Klinik für Hämatologie, Onkologie, Hämostaseologie NOT_YET_RECRUITING Aachen Germany Details
Charité Universitätsmedizin, Comprehensive Cancer Center, Medizinische Klinik m.S. Hämatologie, Onkologie und Tumorimmunologie NOT_YET_RECRUITING Berlin Germany Details
Universitätsklinikum Greifswald, Klinik für Hals-, Nasen-, Ohrenkrankheiten, Kopf- und Halschirurgie NOT_YET_RECRUITING Greifswald Germany Details
Universitätsklinikum Halle (Saale), Klinik und Poliklinik für Innere Medizin IV RECRUITING Halle (Saale) Germany Details
Universitätsklinikum Hamburg, Universitäres Cancer Center Hamburg UCCH, Hubertus Wald Tumorzentrum NOT_YET_RECRUITING Hamburg Germany Details
Klinikum St. Georg gGmbH NOT_YET_RECRUITING Leipzig Germany Details
Universitätsklinikum Leipzig, Klinik und Poliklinik für HNO Heilkunde RECRUITING Leipzig Germany Details
Universitätsklinikum Mainz, III. Medizinische Klinik und Poliklinik RECRUITING Mainz Germany Details
Klinikum Stuttgart, Klinik für Hämatologie, Onkologie und Palliativmedizin RECRUITING Stuttgart Germany Details
Universitätsklinikum Würzburg, Comprehensive Cancer Center Mainfranken NOT_YET_RECRUITING Würzburg Germany Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field